Dianthus Therapeutics

Waltham, United States

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

Mar 2026

Post-IPO Equity

Biopharma Biotechnology Health Care

Top Investors

RA Capital ManagementJanus Henderson InvestorsCatalio Capital ManagementGreat Point PartnersRTW Investments

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dianthus Therapeutics

Who are Dianthus Therapeutics's investors?

Dianthus Therapeutics's investors include RA Capital Management, Janus Henderson Investors, Catalio Capital Management, Great Point Partners, RTW Investments.

Where is Dianthus Therapeutics headquartered?

Dianthus Therapeutics is headquartered in Waltham, United States.

What does Dianthus Therapeutics do?

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

What stage is Dianthus Therapeutics at?

Dianthus Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 10, 2026.

MLA

"Dianthus Therapeutics — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/dianthus-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). Dianthus Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/dianthus-therapeutics

Wikipedia (cite web)

{{cite web |title=Dianthus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dianthus-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 10, 2026.